The prevalence of injection-site reactions with disease-modifying therapies and their effect on adherence in patients with multiple sclerosis: an observational study

BACKGROUND: Interferon beta (IFNβ) and glatiramer acetate (GA) are administered by subcutaneous (SC) or intramuscular (IM) injection. Patients with multiple sclerosis (MS) often report injection-site reactions (ISRs) as a reason for noncompliance or switching therapies. The aim of this study was to...

Descripción completa

Detalles Bibliográficos
Autores principales: Beer, Karsten, Müller, Martin, Hew-Winzeler, Anna Marie, Bont, Adriano, Maire, Philippe, You, Xiaojun, Foulds, Pamela, Mårlind, Jessica, Curtius, Daniela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3227610/
https://www.ncbi.nlm.nih.gov/pubmed/22074056
http://dx.doi.org/10.1186/1471-2377-11-144

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3227610/
https://www.ncbi.nlm.nih.gov/pubmed/22074056
http://dx.doi.org/10.1186/1471-2377-11-144

Ejemplares similares